Form 4: scPharmaceuticals CEO Sells Shares to Cover Tax Obligations

John H. Tucker, CEO of scPharmaceuticals Inc., sold 13,360 shares of common stock on January 3, 2025, to satisfy tax withholding obligations related to vesting restricted stock units.

Summary

• John H. Tucker, the President and CEO of scPharmaceuticals Inc., sold 13,360 shares of the company's common stock on January 3, 2025.
• The sale was executed to cover tax withholding obligations arising from the vesting of restricted stock units.
• The shares were sold at a weighted average price of $3.5587, with individual transactions ranging from $3.48 to $3.62.
• Following the transaction, Tucker directly owns 240,847 shares of scPharmaceuticals Inc.
• The sale was conducted under a Rule 10b5-1 trading plan adopted on August 20, 2024.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale for tax obligations) by the CEO, which is neither particularly positive nor negative. The use of a 10b5-1 plan suggests transparency and pre-planning.

Industry Context

Executive stock sales are a common occurrence, often related to personal financial planning or tax obligations. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on inside information.

Stakeholder Impact

• The stock sale could have a minor impact on shareholders due to the increased supply of shares, but the pre-planned nature of the sale mitigates concerns about insider information.

Key Dates